Donate Help Contact The AHA Sign In Home
American Heart Association
Arteriosclerosis, Thrombosis, and Vascular Biology
Search: search_blue_button Advanced Search
Arteriosclerosis, Thrombosis, and Vascular Biology. 1989;9:550-559

This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Langeler, E. G.
Right arrow Articles by van Hinsbergh, V. W.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Langeler, E. G.
Right arrow Articles by van Hinsbergh, V. W.

Arteriosclerosis, Vol 9, 550-559, Copyright © 1989 by American Heart Association


ARTICLES

Passage of low density lipoproteins through monolayers of human arterial endothelial cells. Effects of vasoactive substances in an in vitro model

EG Langeler, I Snelting-Havinga and VW van Hinsbergh
Gaubius Institute TNO, Leiden, The Netherlands.

The endothelium controls the influx of lipoproteins into the arterial wall, a process that may be disturbed in arteriosclerotic blood vessels. We have used an in vitro model to investigate the characteristics of the passage of low density lipoproteins (LDL) through monolayers of human arterial endothelial cells. Umbilical artery, aorta, or carotid artery endothelial cells were cultured on polycarbonate filters and formed a tight monolayer in which the cells were connected by tight junctions. Passage of 125I-LDL through these monolayers proceeded linearly over a 24-hour period. It was threefold lower through monolayers of aorta or carotid artery cells than through monolayers of umbilical artery cells. The LDL passage process did not show saturation with LDL concentrations up to 800 micrograms/ml LDL- protein (i.e., 1.6 nmol/ml apolipoprotein B) between 2 and 4 hours after addition. However, during the first 30 to 60 minutes after addition of high concentrations of LDL, a reduction of the passage rate of both LDL and peroxidase, resulting in an apparent saturation of the passage process, was observed. The passage rate of the negatively charged acetylated LDL was twofold lower than that of native LDL. Addition of histamine to the endothelial monolayer resulted in a large, but transient, increase in permeability paralleled by a decrease in electrical resistance. The effects of histamine were mediated via an H1 receptor. Thrombin and Ca++ ionophore also induced an increase in permeability of the monolayer, while bradykinin did not. The effects of histamine and thrombin were paralleled by a rapid and marked increase in cytoplasmatic Ca++ concentration of the endothelial cells, while bradykinin induced only a small increase. Although the cyclic adenosine 5'-monophosphate-elevating agent, forskolin, markedly decreased the basal rate of LDL passage through the endothelial cell monolayers, it did not change the relative increase in permeability induced by histamine. Thus, histamine induces small, but significant, increases in the permeability of tight endothelial cell monolayers.


This article has been cited by other articles:


Home page
Am. J. Physiol. Lung Cell. Mol. Physiol.Home page
P. J. Farmer, S. G. Bernier, A. Lepage, G. Guillemette, D. Regoli, and P. Sirois
Permeability of endothelial monolayers to albumin is increased by bradykinin and inhibited by prostaglandins
Am J Physiol Lung Cell Mol Physiol, April 1, 2001; 280(4): L732 - L738.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
G. P. v. N. Amerongen, M. A. Vermeer, P. Negre-Aminou, J. Lankelma, J. J. Emeis, and V. W. M. van Hinsbergh
Simvastatin Improves Disturbed Endothelial Barrier Function
Circulation, December 5, 2000; 102(23): 2803 - 2809.
[Abstract] [Full Text] [PDF]


Home page
JCBHome page
B. Dehouck, L. Fenart, M.-P. Dehouck, A. Pierce, G. Torpier, and R. Cecchelli
A New Function for the LDL Receptor: Transcytosis of LDL across the Blood-Brain Barrier
J. Cell Biol., August 25, 1997; 138(4): 877 - 889.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
W. Liao, M. Rudling, and B. Angelin
Novel Effects of Histamine on Lipoprotein Metabolism: Suppression of Hepatic Low Density Lipoprotein Receptor Expression and Reduction of Plasma High Density Lipoprotein Cholesterol in the Rat
Endocrinology, May 1, 1997; 138(5): 1863 - 1870.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
R. Draijer, A. B. Vaandrager, C. Nolte, H. R. de Jonge, U. Walter, and V. W.M. van Hinsbergh
Expression of cGMP-Dependent Protein Kinase I and Phosphorylation of Its Substrate, Vasodilator-Stimulated Phosphoprotein, in Human Endothelial Cells of Different Origin
Circ. Res., November 1, 1995; 77(5): 897 - 905.
[Abstract] [Full Text]


Home page
Circ. Res.Home page
R. Draijer, D. E. Atsma, A. van der Laarse, and V. W.M. van Hinsbergh
cGMP and Nitric Oxide Modulate Thrombin-Induced Endothelial Permeability : Regulation via Different Pathways in Human Aortic and Umbilical Vein Endothelial Cells
Circ. Res., February 1, 1995; 76(2): 199 - 208.
[Abstract] [Full Text]


Home page
Toxicol PatholHome page
F. D. Kolodgie, P. S. Wilson, J. F. Cornhill, E. E. Herderick, W. J. Mergner, and R. Virmani
Increased Prevalence of Aortic Fatty Streaks in Cholesterol-Fed Rabbits Administered Intravenous Cocaine: The Role of Vascular Endothelium*1
Toxicol Pathol, September 1, 1993; 21(5): 425 - 435.
[Abstract] [PDF]